Velcade, Melphalan, Prednisone And Thalidomide Versus Velcade, Melphalan, Prednisone in Multiple Myeloma Patients
Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
The proposed study will evaluate whether the combination of VELCADE, Thalidomide , Melphalan
and Prednisone (V-MPT), as induction treatment for newly diagnosed elderly MM patients,
improves outcomes compared to the combination VELCADE-MP.